O Schulz, DJ Pennington, K Hodivala-Dilke, M Febbraio, C Reis e Sousa. (2002) " CD36 or alphavbeta3 and alphavbeta5 integrins are not essential for MHC class I cross-presentation of cell-associated antigen by CD8 alpha+ murine dendritic cells. " J Immunol 168. 6057-65 PMID: 12055214 | Abstract and Keywords
C Peters, X Peng, D Douven, ZK Pan, Y Paterson. (2003) " The induction of HIV Gag-specific CD8+ T cells in the spleen and gut-associated lymphoid tissue by parenteral or mucosal immunization with recombinant Listeria monocytogenes HIV Gag. " J Immunol 170. 5176-87 PMID: 12734365 | Abstract and Keywords
DW Mullins, SL Sheasley, RM Ream, TN Bullock, YX Fu, VH Engelhard. (2003) " Route of immunization with peptide-pulsed dendritic cells controls the distribution of memory and effector T cells in lymphoid tissues and determines the pattern of regional tumor control. " J Exp Med 198. 1023-34 PMID: 14530375 DOI: 10.1084/jem.20021348 | Abstract and Keywords
AK Nussbaum, JL Whitton. (2004) " The contraction phase of virus-specific CD8+ T cells is unaffected by a pan-caspase inhibitor. " J Immunol 173. 6611-8 PMID: 15557151 DOI: 15557151 | Abstract and Keywords
PJ Kim, SY Pai, M Brigl, GS Besra, J Gumperz, IC Ho. (2006) " GATA-3 regulates the development and function of invariant NKT cells. " J Immunol 177. 6650-9 PMID: 17082577 | Abstract and Keywords
AN Courtney, P Thapa, S Singh, AM Wishahy, D Zhou, J Sastry. (2011) " Intranasal but not intravenous delivery of the adjuvant α-galactosylceramide permits repeated stimulation of natural killer T cells in the lung. " Eur J Immunol 41. 3312-22 PMID: 21818755 DOI: 10.1002/eji.201041359 | Abstract and Keywords
OE Rahma, E Ashtar, M Czystowska, ME Szajnik, E Wieckowski, S Bernstein, VE Herrin, MA Shams, SM Steinberg, M Merino, W Gooding, C Visus, AB Deleo, JK Wolf, JG Bell, JA Berzofsky, TL Whiteside, SN Khleif. (2011) " A gynecologic oncology group phase II trial of two p53 peptide vaccine approaches: subcutaneous injection and intravenous pulsed dendritic cells in high recurrence risk ovarian cancer patients. " Cancer Immunol Immunother 61. 373-84 PMID: 21927947 DOI: 10.1007/s00262-011-1100-9 | Abstract and Keywords